Omega Healthcare Investors (NYSE:OHI) Sets New 52-Week High - Here's What Happened

Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as $42.08 and last traded at $41.98, with a volume of 51735 shares. The stock had previously closed at $41.88.

Analyst Ratings Changes

Several research firms recently weighed in on OHI. Mizuho downgraded Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and lifted their target price for the company from $34.00 to $35.00 in a research report on Thursday, July 25th. Truist Financial lifted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research report on Wednesday, September 4th. Scotiabank increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a report on Monday, August 26th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Finally, BMO Capital Markets upped their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a "market perform" rating in a research report on Monday, October 7th. Eight analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $37.80.

Omega Healthcare Investors Stock Performance

The company has a market capitalization of $10.97 billion, a P/E ratio of 31.97, a P/E/G ratio of 1.34 and a beta of 1.00. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. The business's fifty day simple moving average is $40.25 and its 200-day simple moving average is $35.79.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The company's revenue for the quarter was up 17.5% compared to the same quarter last year. During the same period last year, the firm posted $0.74 earnings per share. As a group, equities analysts anticipate that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a $0.67 dividend. The ex-dividend date is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.30%. Omega Healthcare Investors's payout ratio is currently 204.58%.

Insider Transactions at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OHI. Vanguard Group Inc. raised its stake in shares of Omega Healthcare Investors by 0.5% during the first quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust's stock valued at $1,120,478,000 after acquiring an additional 165,105 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock worth $127,831,000 after buying an additional 272,299 shares in the last quarter. Bank of New York Mellon Corp grew its position in shares of Omega Healthcare Investors by 4.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust's stock worth $110,971,000 after buying an additional 143,521 shares in the last quarter. LSV Asset Management increased its stake in shares of Omega Healthcare Investors by 0.7% during the second quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust's stock valued at $67,411,000 after buying an additional 14,000 shares during the period. Finally, Daiwa Securities Group Inc. raised its holdings in shares of Omega Healthcare Investors by 1,030.8% in the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust's stock valued at $32,384,000 after acquiring an additional 861,907 shares in the last quarter. Institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.